Susceptibility to Infection and Impact of COVID-19 Vaccines on Symptoms of Women with Endometriosis: A Systematic Review and Meta-Analysis of Available Evidence

Overview

Journal Reprod Sci

Publisher Springer

Specialty Reproductive Medicine

Date 2024 Sep 27

PMID 39331336

Authors

Gaetano Riemma

Andrea Etrusco

Antonio Simone Lagana

Marco Torella

Maria Giovanna Vastarella

Luigi Della Corte

Antonio Damato

Marco La Verde

Pasquale De Franciscis

Luigi Cobellis

Affiliations

Soon will be listed here.

Abstract

Women with endometriosis were deemed more prone to COVID-19 infection in some reports. Considering that endometriosis-related aberrant immune response, understanding how COVID-19 vaccination influences its clinical status is crucial. The aim of this meta-analysis was the evaluate the susceptibility to COVID-19 infection and modifications of symptoms following COVID-19 vaccination in women with endometriosis. Electronic searches on EMBASE, MEDLINE, Scopus, Cochrane at CENTRAL, Scielo.br, LILACS and other databases were searched from inception to March 2024. Studies were eligible if they analyzed the incidence of infection in endometriosis women or the changes in symptoms after two doses of COVID-19 vaccine and had a control group. Four studies (2249 women) were included. No increased susceptibility to COVID-19 infection due to presence or absence of endometriosis was retrievable (risk ratio (RR) 1.42 [95% CI 0.88 to 2.27]; I = 33%). Patients with endometriosis did not experience an overall worsening of symptomatology relative to controls (RR 1.58 [95% CI 0.67 to 3.75]; I = 94%). An increase in the risk of dysmenorrhea worsening was noted (RR 1.88 [95% CI 1.11 to 3.17]; I = 63%). No other differences regarding menstrual flow (RR 1.25 [95% CI 0.70 to 2.23]; I = 78%), intermenstrual bleeding (RR 1.14 [95% CI 0.83 to 1.56]; I = 39%) and pelvic pain (RR 2.55 [95% CI 0.65 to 10.05]; I = 80%) compared to controls was retrievable. Therefore, mRNA vaccines do not seem to lead to worsening of symptomatology in endometriotic women. However, a slight temporary increase in dysmenorrhea may be present. Moreover, endometriosis does not seem to increase the risk of contracting COVID-19.

References

Riemma G, De Franciscis P, La Verde M, Ravo M, Fumiento P, Fasulo D . Impact of the hemostatic approach after laparoscopic endometrioma excision on ovarian reserve: Systematic review and network meta-analysis of randomized controlled trials. Int J Gynaecol Obstet. 2022; 162(1):222-232. DOI: 10.1002/ijgo.14621. View

Mormile R . Endometriosis and susceptibility to COVID-19 infection: a floating river without blanks?. Arch Gynecol Obstet. 2023; 309(4):1695-1696. DOI: 10.1007/s00404-023-07337-6. View

Augoulea A, Alexandrou A, Creatsa M, Vrachnis N, Lambrinoudaki I . Pathogenesis of endometriosis: the role of genetics, inflammation and oxidative stress. Arch Gynecol Obstet. 2012; 286(1):99-103. DOI: 10.1007/s00404-012-2357-8. View

Edelman A, Boniface E, Male V, Cameron S, Benhar E, Han L . Timing of Coronavirus Disease 2019 (COVID-19) Vaccination and Effects on Menstrual Cycle Changes. Obstet Gynecol. 2024; 143(4):585-594. PMC: 10953681. DOI: 10.1097/AOG.0000000000005550. View

Fallatah N, Alrehaili B, Alsulami S, Al-Zalabani A . Menstrual Changes Following COVID-19 Vaccination: A Cross-Sectional Study. Medicina (Kaunas). 2024; 60(2). PMC: 10890281. DOI: 10.3390/medicina60020206. View

Koninckx P, Ussia A, Adamyan L, Gomel V, Martin D . Peritoneal fluid progesterone and progesterone resistance in superficial endometriosis lesions. Hum Reprod. 2021; 37(2):203-211. DOI: 10.1093/humrep/deab258. View

Serifoglu H, Arinkan S, Pasin O, Vural F . Is there an association between endometriosis and thyroid autoimmunity?. Rev Assoc Med Bras (1992). 2023; 69(6):e20221679. PMC: 10234359. DOI: 10.1590/1806-9282.20221679. View

Greenbaum H, Galper B, Decter D, Eisenberg V . Endometriosis and autoimmunity: Can autoantibodies be used as a non-invasive early diagnostic tool?. Autoimmun Rev. 2021; 20(5):102795. DOI: 10.1016/j.autrev.2021.102795. View

Eisenberg V, Zolti M, Soriano D . Is there an association between autoimmunity and endometriosis?. Autoimmun Rev. 2012; 11(11):806-14. DOI: 10.1016/j.autrev.2012.01.005. View

10.

Bettini E, Locci M . SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond. Vaccines (Basel). 2021; 9(2). PMC: 7918810. DOI: 10.3390/vaccines9020147. View

11.

Male V . Menstrual changes after covid-19 vaccination. BMJ. 2021; 374:n2211. DOI: 10.1136/bmj.n2211. View

12.

Tandon A, Kumar N, Aggarwal S, Anjana Y, Sachdeva M, Gupta V . Assessing Menstrual Changes Among Young Indian Females Post-SARS-CoV-2 Vaccination. Cureus. 2024; 15(12):e50025. PMC: 10767692. DOI: 10.7759/cureus.50025. View

13.

Li J, Bai J, Xiang X, Guo Y, Yu H . Effect of COVID-19 on Menstruation and Lower Reproductive Tract Health. Int J Womens Health. 2023; 15:1999-2013. PMC: 10752023. DOI: 10.2147/IJWH.S433516. View

14.

Torella M, Marrapodi M, Ronsini C, Ruffolo A, Braga A, Frigerio M . Risk of Premature Ovarian Insufficiency after Human Papilloma Virus Vaccination: A PRISMA Systematic Review and Meta-Analysis of Current Evidence. Vaccines (Basel). 2023; 11(1). PMC: 9866915. DOI: 10.3390/vaccines11010140. View

15.

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLoS Med. 2021; 18(3):e1003583. PMC: 8007028. DOI: 10.1371/journal.pmed.1003583. View

16.

Hartling L, Milne A, Hamm M, Vandermeer B, Ansari M, Tsertsvadze A . Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers. J Clin Epidemiol. 2013; 66(9):982-93. DOI: 10.1016/j.jclinepi.2013.03.003. View

17.

Martinez-Zamora M, Feixas G, Gracia M, Rius M, Quintas L, de Guirior C . Evaluation of menstrual symptoms after Coronavirus disease 2019 vaccination in women with endometriosis. Womens Health (Lond). 2023; 19:17455057231176751. PMC: 10251079. DOI: 10.1177/17455057231176751. View

18.

Gilan A, Laster-Haim S, Rottenstreich A, Porat S, Lessans N, Saar T . The effect of SARS-CoV-2 BNT162b2 vaccine on the symptoms of women with endometriosis. Arch Gynecol Obstet. 2022; 307(1):121-127. PMC: 9468530. DOI: 10.1007/s00404-022-06765-0. View

19.

Barretta M, Savasta F, Pietropaolo G, Barbasetti A, Barbera V, Vignali M . COVID-19 susceptibility in endometriosis patients: A case control study. Am J Reprod Immunol. 2022; 88(4):e13602. PMC: 9349658. DOI: 10.1111/aji.13602. View

20.

Moazzami B, Chaichian S, Samie S, Zolbin M, Jesmi F, Akhlaghdoust M . Does endometriosis increase susceptibility to COVID-19 infections? A case-control study in women of reproductive age. BMC Womens Health. 2021; 21(1):119. PMC: 7983080. DOI: 10.1186/s12905-021-01270-z. View